Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
INO80D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IL18BP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZCCHC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOPC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FYN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPTLC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDIA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DTNA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL2RG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STX12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC93 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAM30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCCIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OCLN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on